DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$10.80
+1.41% today
Updated 2026-04-30
Market cap
$59.73M
P/E ratio
6.25
P/S ratio
2,238.07x
EPS (TTM)
$1.64
Dividend yield
—
52W range
$7 – $15
Volume
0.0M
Daxor Corporation (DXR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
34,359.00%
Operating margin
-9,661.00%
ROE
22.50%
ROA
-1.64%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.49M | $-785531.00 | 61.94% | -52.85% | -52.85% |
| 2007 | $1.87M | $10.65M | 74.55% | 639.55% | 569.44% |
| 2008 | $1.76M | $15.12M | 70.70% | 1,117.58% | 858.76% |
| 2009 | $1.69M | $5.82M | 58.26% | 423.48% | 344.78% |
| 2010 | $1.58M | $4.97M | 53.92% | 528.74% | 314.60% |
| 2011 | $1.28M | $-7.19M | 48.92% | -452.98% | -562.51% |
| 2012 | $-2.10M | $1.19M | 100.00% | 127.73% | -56.46% |
| 2013 | $-11.56M | $-8.22M | 100.00% | 71.11% | 71.11% |
| 2014 | $-4.05M | $-976703.00 | 100.00% | 111.18% | 24.09% |
| 2015 | $-7.44M | $-9.15M | 104.23% | 105.87% | 122.87% |
| 2016 | $1.84M | $1.46M | 84.92% | 79.95% | 79.32% |
| 2017 | $-1.01M | $-1.24M | 100.00% | 112.92% | 122.57% |
| 2018 | $-918449.00 | $-885775.00 | 100.00% | 119.45% | 96.44% |
| 2019 | $-114992.00 | $-495697.00 | 100.00% | 431.07% | 431.07% |
| 2020 | $-996299.00 | $-1.71M | 100.00% | 173.71% | 171.17% |
| 2021 | $5.82M | $4.75M | 100.00% | 81.57% | 81.57% |
| 2022 | $6.31M | $5.18M | 100.00% | 83.21% | 82.06% |
| 2023 | $34.59M | $280640.00 | 99.49% | 0.95% | 0.81% |
| 2024 | $2.13M | $536334.00 | 100.00% | 29.16% | 25.17% |
| 2025 | $503424.00 | $9.17M | 37.49% | 1,824.65% | 1,821.48% |